Skip to content
Screener

CG Oncology CGON Other Non-Current Liabilities

Other Non-Current Liabilities at other companies

Pfizer logo
PfizerPFE
$14.2B+6.8%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$10.1B-1.6%
Gilead Sciences logo
Gilead SciencesGILD
$1.49B+15.5%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$472K+27.6%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
$3.43M-37.6%
Replimune Group logo
Replimune GroupREPL
$693K-45.3%

Other financials

Income statement

See full
Revenue$1.2M—
Operating income-$86.4M-77.3%
Net income-$79.1M-90.8%
EPS (diluted)-$0.90-66.7%

Balance sheet

See full
Cash & equivalents$19.6M+34.3%
Total debt$8.8M+787%
Total equity$1.0B+53.5%
Total assets$1.1B+54.8%

Cash flow

See full
Operating cash flow-$46.4M-66.0%
CapEx$468.0K+3,243%
Free cash flow-$46.9M-67.6%

Valuation

See full
Market cap$6.6B+242%
Enterprise value$6.59B+244%
P/S1,060×-2,439×

Profitability

See full
Operating margin-4,056.2%-1,873pp
Net margin-3,602.7%-1,650pp
FCF margin-2,879.6%-1,307pp

Returns & leverage

See full
Return on equity-26.4%+9.3pp
Debt / equity0×0.0×
Current ratio22.2×+0.1×

Where this comes from

Reported directly by CG Oncology in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.

The source filing: CG Oncology’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 8:45 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-336918

FAQ

What is CG Oncology's other non-current liabilities?
CG Oncology (CGON) reported other non-current liabilities of $1.16M in Q2 2026.
What does other non-current liabilities mean?
Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.

Ask your AI about CG Oncology's other non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude